With the relatively recent arrival of new oral anticoagulants (NOACs) vying to displace warfarin with the promise of fewer side effects, easier dosing and less need for regular monitoring, patients and their doctors have gained valuable new tools to reduce the risks of blood clots. Read More
IMS Institute for Healthcare Informatics is out with its latest prediction for sales of medicines through 2018, when global spending is expected to reach between $1.28 trillion and $1.31 trillion, an increase of $290 million to $320 million over 2013 levels. Read More
With only about 12 trading days remaining this year we take a quick test of biotech's current temperature and tee-up our upcoming end-of-year features that will provide a deeper dive into the sector's 2014 business and financial performance and reflect upon what the future might hold. Read More
